The Globe and Mail reports in its Wednesday, April 29, edition that Sunnybrook Health Sciences Centre will receive a $41-million gift from the Westons to transform clinical trials and improve patient care. The Globe's Kristy Kirkup writes that this contribution will expedite access to promising therapies for patients and advance scientific discoveries nationwide, according to Sunnybrook chief executive officer Andy Smith. He said on Monday, "The more that we can bring more clinical trials, better clinical trials, to Sunnybrook, as to anywhere in Canada, this is going to do great things for patients and families, and by extension, the communities that we serve." The country has the scientific strength and capability to be a global leader for clinical trials, he said, however, that progress can be slowed by factors that include inadequate infrastructure and limited capacity. "The gift is for Sunnybrook, but we really see it as being a catalyst for better achievement as team Canada, our collaboration across Canada." Kelly Cole, president and CEO of the Sunnybrook Foundation, said the contribution is a vote of confidence for the health sciences space, as well as the Canadian health care system.